| 763868 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
438 A phase 1 trial of CUE-101, a novel HPV16 E7-pHLA-IL2-Fc fusion protein, alone and in combination with pembrolizumab in patients with recurrent/metastatic HPV16+ head and neck cancer |
2021-11-01 |
10.1136/jitc-2021-sitc2021.438 |
Chung Christine, Dimitrios Colevas A, Gibson Michael, Adkins Douglas, Sukari Ammar, Wirth Lori, Burtness Barbara, Bauman Julie, Rodriguez Cristina, Worden Francis, Saba Nabil, Glisson Bonnie, Dunn Lara, Seiwert Tanguy, Agensky Laura, Levisetti Matteo, Lynam Reena, Margossian Steven, Moniz Raymond, Quayle Steve, Pienta Kenneth, Pai Sara |
| 763867 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
676 Altered circulating myeloid states associated with anti-PD-1 resistance induce T cell paralysis in human biliary cancer |
2021-11-01 |
10.1136/jitc-2021-sitc2021.676 |
Keenan Bridget, McCarthy Elizabeth, Ilano Arielle, Yang Hai, Zhang Li, Allaire Kathryn, Fan Zenghua, Li Tony, Lee David, Sun Yang, Cheung Alexander, Chang Hewitt, Sheldon Brenna, Kelley Robin, Ye Chun Jimmie, Fong Lawrence |
| 763866 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
325 Eliminating tumor immune privilege through immune checkpoint cytoreduction |
2021-11-01 |
10.1136/jitc-2021-sitc2021.325 |
Winkler Michelle, Curran Michael |
| 763865 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
279 ILT3 blockade reduces tumor blast cells in acute myeloid leukemia PBMC and inhibits tumor cell growth in a humanized AML tumor model |
2021-11-01 |
10.1136/jitc-2021-sitc2021.279 |
Byford Alan, Qu Yujie, Xu Haiyan, Robinson Gain, Singh Latika, Muise Eric, Pinheiro Elaine, Chen Mei, Moy Lily, Alves Stephen, Zhang-Hoover Jie |
| 763864 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
513 Trial in progress: phase 1 first-in-human study of XL092 administered alone or in combination with immune checkpoint inhibitors in patients with inoperable locally advanced or metastatic solid tumors |
2021-11-01 |
10.1136/jitc-2021-sitc2021.513 |
Patnaik Amita, Subbiah Vivek, Shapiro Geoffrey, Pal Sumanta, Agarwal Neeraj, Wentzel Kristopher, Li Jing, McIlvaine Elizabeth, Waldes Jana, Cha Edward, Tadjalli-Mehr Keyvan, Sharma Manish |
| 763863 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
28 Predictions of outcomes and benefit of immune checkpoint inhibitor treatment in NSCLC require information on both tumor and host biology |
2021-11-01 |
10.1136/jitc-2021-sitc2021.028 |
Roder Joanna, Campbell Thomas, Asmellash Senait, Rightmyer Steven, Norman Patrick, Georgantas Robert, McCleland Mark, Zou Wei, Srivastava Minu, Net Lelia, Maguire Laura, Roder Heinrich, Shames David |
| 763862 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
517 LUMINOS-103: a basket trial evaluating the safety and efficacy of PVSRIPO and PVSRIPO in combination with anti-PD-1/L1 checkpoint inhibitors in patients with advanced solid tumors |
2021-11-01 |
10.1136/jitc-2021-sitc2021.517 |
Inman Brant, Milowsky Matthew, Pruthi Raj, Posner Marshall, Polasek Melissa, Morris Shannon, Mixson Lori, Orr Kristin, Woodson Elizabeth, Kelly Andrea, Nichols Garrett, Balar Arjun |
| 763861 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
794 Long-term anti-tumor preclinical efficacy of an optimized anti PD-1/IL-7 bifunctional antibody sustaining activation of progenitor stem-like CD8 TILs and disarming Treg suppressive activity |
2021-11-01 |
10.1136/jitc-2021-sitc2021.794 |
morello Aurore, Seite Margaux, Durand Justine, Teppaz Geraldine, Thepenier Virginie, Mary caroline, Girault Isabelle, Wilhem Emmanuelle, Poirier Nicolas |
| 763860 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
790 DSP502 — A novel approach for targeting TIGIT and PD1 pathways for cancer immunotherapy |
2021-11-01 |
10.1136/jitc-2021-sitc2021.790 |
Chajut Ayelet, Greenwald Shirley, Weber Matthew, Tamir Ami, Pecker Iris, Tabakman Rinat, Ganthous Lucy, Tamir Liat, Kahn Roy, Avichzer Jasmine, Aronin Alexandra, Zorde-Khvalevsky Elina, Peled Amnon, Elhalel Dranitzki Michal Michal, Foley-Comer Adam, Tykocinski Mark |
| 763859 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
646 Transcriptome analysis of tumor and matched infiltrating lymphocytes identifies potential new targets for augmenting intra-tumoral NK function in soft tissue sarcomas |
2021-11-01 |
10.1136/jitc-2021-sitc2021.646 |
Judge Sean, Bloomstein Joshua, Cruz Sylvia, Razmara Aryana, Sholevar Cyrus, Canter Robert |
